{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:57:23Z","timestamp":1792195043887,"version":"4.4.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070912 81773326"],"award-info":[{"award-number":["82070912 81773326"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BE2019676"],"award-info":[{"award-number":["BE2019676"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Cancer cachexia is a multifactorial syndrome defined by progressive loss of body weight with specific depletion of skeletal muscle and adipose tissue. Since there are no FDA-approved drugs that are available, nutritional intervention is recommended as a supporting therapy. Creatine supplementation has an ergogenic effect in various types of sports training, but the regulatory effects of creatine supplementation in cancer cachexia remain unknown. In this study, we investigated the impact of creatine supplementation on cachectic weight loss and muscle loss protection in a tumor-bearing cachectic mouse model, and the underlying molecular mechanism of body weight protection was further assessed. We observed decreased serum creatine levels in patients with cancer cachexia, and the creatine content in skeletal muscle was also significantly decreased in cachectic skeletal muscle in the C26 tumor-bearing mouse model. Creatine supplementation protected against cancer cachexia-associated body weight loss and muscle wasting and induced greater improvements in grip strength. Mechanistically, creatine treatment altered the dysfunction and morphological abnormalities of mitochondria, thus protecting against cachectic muscle wasting by inhibiting the abnormal overactivation of the ubiquitin proteasome system (UPS) and autophagic lysosomal system (ALS). In addition, electron microscopy revealed that creatine supplementation alleviated the observed increase in the percentage of damaged mitochondria in C26 mice, indicating that nutritional intervention with creatine supplementation effectively counteracts mitochondrial dysfunction to mitigate muscle loss in cancer cachexia. These results uncover a previously uncharacterized role for creatine in cachectic muscle wasting by modulating cellular energy metabolism to reduce the level of muscle cell atrophy.<\/jats:p>","DOI":"10.3389\/fphar.2022.1086662","type":"journal-article","created":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T04:53:59Z","timestamp":1670388839000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Creatine modulates cellular energy metabolism and protects against cancer cachexia-associated muscle wasting"],"prefix":"10.3389","volume":"13","author":[{"given":"Lulu","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junaid","family":"Wazir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyuan","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panpan","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renwei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/s0167-5273(02)00470-9","article-title":"How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH","volume":"86","author":"Anker","year":"2002","journal-title":"Int. J. Cardiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1016\/j.bbrc.2009.12.123","article-title":"Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia","volume":"391","author":"Benny Klimek","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B4","doi-asserted-by":"publisher","first-page":"C392","DOI":"10.1152\/ajpcell.00125.2016","article-title":"The ubiquitin proteasome system in atrophying skeletal muscle: Roles and regulation","volume":"311","author":"Bilodeau","year":"2016","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1126\/science.1065874","article-title":"Identification of ubiquitin ligases required for skeletal muscle atrophy","volume":"294","author":"Bodine","year":"2001","journal-title":"Science"},{"key":"B6","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/jcsm.12178","article-title":"Mitochondria and ageing: Role in heart, skeletal muscle and adipose tissue","volume":"8","author":"Boengler","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1242\/dmm.010389","article-title":"Cellular and molecular mechanisms of muscle atrophy","volume":"6","author":"Bonaldo","year":"2013","journal-title":"Dis. Model. Mech."},{"key":"B8","doi-asserted-by":"publisher","first-page":"116467","DOI":"10.1016\/j.bone.2022.116467","article-title":"Creatine supplementation for older adults: Focus on sarcopenia, osteoporosis, frailty and Cachexia","volume":"162","author":"Candow","year":"2022","journal-title":"Bone"},{"key":"B9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00360-019-01245-5","article-title":"Autophagy and Akt-mTOR signaling display periodic oscillations during torpor-arousal cycles in oxidative skeletal muscle of Daurian ground squirrels (Spermophilus dauricus)","volume":"190","author":"Chang","year":"2020","journal-title":"J. Comp. Physiol. B"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2013.03.018","article-title":"Mitochondrial diseases of the brain","volume":"63","author":"Chaturvedi","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"B11","first-page":"231","article-title":"Sur la composition chimique du bouillon de viandes","volume":"21","author":"Chevreul","year":"1835","journal-title":"J. Pharm. Sci. Access"},{"key":"B12","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.cmet.2007.09.009","article-title":"The E3 ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle","volume":"6","author":"Clarke","year":"2007","journal-title":"Cell Metab."},{"key":"B13","first-page":"721s","article-title":"Pathophysiology of cancer cachexia: Current understanding and areas for future research","volume":"42","author":"DeWys","year":"1982","journal-title":"Cancer Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: An international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet. Oncol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1172\/JCI32827","article-title":"Myosin accumulation and striated muscle myopathy result from the loss of muscle RING finger 1 and 3","volume":"117","author":"Fielitz","year":"2007","journal-title":"J. Clin. Invest."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.3390\/ijms21072321","article-title":"Cancer cachexia and related metabolic dysfunction","volume":"21","author":"Fonseca","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"14440","DOI":"10.1073\/pnas.251541198","article-title":"Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy","volume":"98","author":"Gomes","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B18","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s00726-011-1132-7","article-title":"In sickness and in health: The widespread application of creatine supplementation","volume":"43","author":"Gualano","year":"2012","journal-title":"Amino Acids"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1002\/cncr.22944","article-title":"A placebo-controlled double blind trial of etanercept for the cancer anorexia\/weight loss syndrome: Results from N00C1 from the north central cancer treatment group","volume":"110","author":"Jatoi","year":"2007","journal-title":"Cancer"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.21037\/tlcr-21-600","article-title":"Prognostic and predictive impact of creatine kinase level in non-small cell lung cancer treated with tyrosine kinase inhibitors","volume":"10","author":"Jiang","year":"2021","journal-title":"Transl. Lung Cancer Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e15016","DOI":"10.14814\/phy2.15016","article-title":"Voluntary exercise prevents abnormal muscle mitochondrial morphology in cancer cachexia mice","volume":"9","author":"Kitaoka","year":"2021","journal-title":"Physiol. Rep."},{"key":"B22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1096\/fj.03-0610com","article-title":"Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression","volume":"18","author":"Lecker","year":"2004","journal-title":"FASEB J."},{"key":"B23","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12931-021-01765-1","article-title":"Mitochondrial creatine kinase 1 in non-small cell lung cancer progression and hypoxia adaptation","volume":"22","author":"Li","year":"2021","journal-title":"Respir. Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"307","DOI":"10.4161\/auto.6.2.11137","article-title":"Autophagy inhibition induces atrophy and myopathy in adult skeletal muscles","volume":"6","author":"Masiero","year":"2010","journal-title":"Autophagy"},{"key":"B25","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/jcsm.12654","article-title":"Effects of statins on mitochondrial pathways","volume":"12","author":"Mollazadeh","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B26","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/ajcn\/83.4.735","article-title":"Cachexia: Pathophysiology and clinical relevance","volume":"83","author":"Morley","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"B27","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3390\/nu13020490","article-title":"Creatine metabolism in female reproduction, pregnancy and newborn health","volume":"13","author":"Muccini","year":"2021","journal-title":"Nutrients"},{"key":"B28","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.1111\/bph.15625","article-title":"Inhibition of heat shock protein (HSP) 90 reverses signal transducer and activator of transcription (STAT) 3-mediated muscle wasting in cancer cachexia mice","volume":"178","author":"Niu","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3390\/nu3080735","article-title":"Metabolic agents that enhance ATP can improve cognitive functioning: A Review of the evidence for glucose, oxygen, pyruvate, creatine, and L-carnitine","volume":"3","author":"Owen","year":"2011","journal-title":"Nutrients"},{"key":"B30","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/jcsm.12525","article-title":"Nutrition interventions to treat low muscle mass in cancer","volume":"11","author":"Prado","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B31","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1096\/fj.06-6604com","article-title":"Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases","volume":"21","author":"Sacheck","year":"2007","journal-title":"FASEB J."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1002\/jcsm.12760","article-title":"Exogenous insulin-like growth factor 1 attenuates cisplatin-induced muscle atrophy in mice","volume":"12","author":"Sakai","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B33","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/MCO.0b013e328331de63","article-title":"Can the use of creatine supplementation attenuate muscle loss in cachexia and wasting?","volume":"12","author":"Sakkas","year":"2009","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1111\/febs.12253","article-title":"Mechanisms regulating skeletal muscle growth and atrophy","volume":"280","author":"Schiaffino","year":"2013","journal-title":"FEBS J."},{"key":"B35","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.bbadis.2005.09.004","article-title":"Mitochondrial creatine kinase in human health and disease","volume":"1762","author":"Schlattner","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"B36","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/978-1-4020-6486-9_16","article-title":"Creatine and creatine kinase in health and disease-a bright future ahead?","volume":"46","author":"Wyss","year":"2007","journal-title":"Subcell. Biochem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"eabc1586","DOI":"10.1126\/sciadv.abc1586","article-title":"Gadofullerene inhibits the degradation of apolipoprotein B100 and boosts triglyceride transport for reversing hepatic steatosis","volume":"6","author":"Zhou","year":"2020","journal-title":"Sci. Adv."},{"key":"B38","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1086662\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T04:54:03Z","timestamp":1670388843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1086662\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,7]]},"references-count":38,"alternative-id":["10.3389\/fphar.2022.1086662"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.1086662","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,7]]},"article-number":"1086662"}}